Bioventus Inc. Quarterly Accounts Payable, Current in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Bioventus Inc. quarterly Accounts Payable, Current history and growth rate from Q4 2020 to Q3 2024.
  • Bioventus Inc. Accounts Payable, Current for the quarter ending September 28, 2024 was $16.8M, a 4.47% decline year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $16.8M -$788K -4.47% Sep 28, 2024 10-Q 2024-11-05
Q2 2024 $24.4M -$16.9M -40.9% Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $19.1M -$13.7M -41.8% Mar 30, 2024 10-Q 2024-05-07
Q4 2023 $23M -$13.7M -37.2% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $17.6M -$1.44M -7.54% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $41.4M +$15.6M +60.7% Jul 1, 2023 10-Q 2023-08-08
Q1 2023 $32.8M +$10.3M +45.9% Apr 1, 2023 10-Q 2023-05-16
Q4 2022 $36.7M +$19.8M +117% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $19.1M +$8.18M +75% Oct 1, 2022 10-Q 2022-11-21
Q2 2022 $25.7M +$15.9M +160% Jul 2, 2022 10-Q 2022-08-12
Q1 2022 $22.5M +$12.2M +119% Apr 2, 2022 10-Q 2022-05-11
Q4 2021 $16.9M +$12.5M +283% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $10.9M Oct 2, 2021 10-Q 2021-11-10
Q2 2021 $9.88M Jul 3, 2021 10-Q 2021-08-11
Q1 2021 $10.3M Apr 3, 2021 10-Q 2021-05-13
Q4 2020 $4.42M Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.